Schonfeld Strategic Advisors LLC 9 Meters Biopharma, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $4,992 - $12,288	19,200 Added 21.24%	109,600 $29,000
Q1 2022 May 16, 2022	BUY	$0.52 - $1.0 $5,720 - $11,000	11,000 Added 13.85%	90,400 $54,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $34,085 - $53,333	40,100 Added 102.04%	79,400 $78,000
Q3 2021 Nov 16, 2021	BUY	$1.03 - $1.41 $40,479 - $55,413	39,300 New	39,300 $51,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $59,548 - $85,887	-57,258 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $48,096 - $123,677	57,258 New	57,258 $67,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.